World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
82
Citations
28717
World Ranking
1488
National Ranking
749

Medicine

D-Index
83
Citations
29517
World Ranking
15481
National Ranking
7808

Overview

Evan M. Hersh was affiliated with The University of Texas MD Anderson Cancer Center in the United States during their academic career. Their work was situated within a leading cancer research institution, contributing to the scientific community through their involvement in this prominent center.

Although specific details about their fields of study, subfields, main topics of work, and publication record are not available, the association with MD Anderson Cancer Center suggests a focus likely related to cancer research or oncology. No records of recent papers, frequent co-authors, or recurring publication venues were provided to outline further details of their research contributions.

There are no records of book publications or awards linked to Evan M. Hersh. The absence of these data points means there are no documented recognitions or extended authorship contributions such as monographs or edited volumes known from this profile.

Given that Evan M. Hersh is deceased, all references to their work and affiliations are presented in past tense consistent with standard biographical conventions. Their contributions remain part of the academic fabric, although specific publication and research details have not been cataloged in the provided data.

Best Publications

  • A new type of synthetic peptide library for identifying ligand-binding activity

    Kit S. Lam;Sydney E. Salmon;Evan M. Hersh;Victor J. Hruby

  • Non-Hodgkin's Lymphoma in 90 Homosexual Men: Relation to Generalized Lymphadenopathy and the Acquired Immunodeficiency Syndrome

    John L. Ziegler;Jay A. Beckstead;Paul A. Volberding;Donald I. Abrams

  • Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia

    Jorge R. Quesada;James M Reuben;John T. Manning;Evan M. Hersh

  • Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

    Jordan U. Gutterman;George R. Blumenschein;Raymond Alexanian;Hwee-Yong Yap

  • Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

    Agop Y. Bedikian;Michael Millward;Hubert Pehamberger;Robert Conry

  • Phase I/II study of ipilimumab for patients with metastatic melanoma

    Jeffrey S. Weber;Steven O’Day;Walter Urba;John Powderly

  • Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study

    Gabriel Lopez-Berestein;Victor Fainstein;Roy Hopfer;Kapil Mehta

  • Impaired in vitro lymphocyte transformation in Hodgkin's disease.

    Evan M. Hersh;Joost J. Oppenheim

  • Local drug and gene delivery through microbubbles

    Evan C Unger;Evan Hersh;Mani Vannan;Terry O Matsunaga

  • A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.

    Evan M. Hersh;Steven J. O’Day;John Powderly;Khuda D. Khan

  • Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies.

    David W. Nyman;Kimberley J. Campbell;Evan Hersh;Kristen Long

  • Treatment and Prophylaxis of Disseminated Infection Due to Candida albicans in Mice with Liposome-Encapsulated Amphotericin B

    G. Lopez-Berestein;R. Mehta;R. L. Hopfer;K. Mills

  • Chemotherapy, Immunocompetence, Immunosuppression and Prognosis in Acute Leukemia

    Evan M. Hersh;John P. Whitecar;Kenneth B. Mccredie;Gerald P. Bodey

  • Cells Capable of Colony Formation in the Peripheral Blood of Man

    Kenneth B. McCredie;Evan M. Hersh;Emil J Freireich

  • Macrophage-Lymphocyte Interaction in the Antigen-Induced Blastogenic Response of Human Peripheral Blood Leukocytes

    Evan M. Hersh;Jules E. Harris

  • Treatment of hairy cell leukemia with recombinant alpha-interferon.

    JR Quesada;EM Hersh;J Manning;J Reuben

  • Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma : A Report From the 11715 Study Group

    David F. McDermott;Jeffrey A. Sosman;Rene Gonzalez;F. Stephen Hodi

  • The Transformation of Column-Purified Lymphocytes with Nonspecific and Specific Antigenic Stimuli

    Joost J. Oppenheim;Brigid G. Leventhal;Evan M. Hersh

  • ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMA

    J.U Gutterman;C McBride;E.J Freireich;G Mavligit

  • Pharmacokinetics of recombinant interleukin 2 in humans.

    Michael W. Konrad;George Hemstreet;Evan M. Hersh;Peter W. A. Mansell

Frequent Co-Authors

Jordan U. Gutterman
Jordan U. Gutterman The University of Texas MD Anderson Cancer Center
James M. Reuben
James M. Reuben The University of Texas MD Anderson Cancer Center
Roger D. Rossen
Roger D. Rossen Baylor College of Medicine
Gabriel N. Hortobagyi
Gabriel N. Hortobagyi The University of Texas MD Anderson Cancer Center
Gerald P. Bodey
Gerald P. Bodey The University of Texas MD Anderson Cancer Center
Steven J. O'Day
Steven J. O'Day St. John's University
Kapil Mehta
Kapil Mehta MolQ Laboratory
George R. Blumenschein
George R. Blumenschein The University of Texas MD Anderson Cancer Center
Jeffrey S. Weber
Jeffrey S. Weber New York University
Emil J. Freireich
Emil J. Freireich The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can provide diverse career opportunities. Nursing pathways, for example, often complement immunological knowledge, especially in specialized fields like psychiatric or acute care. If you're considering advancing in nursing, programs such as the cheapest pmhnp programs offer accessible ways to specialize in psychiatric mental health as a nurse practitioner.

Additionally, transitioning within nursing specialties is a common pathway. For example, nurses aiming to shift from family practice to acute care might find guidance through resources on fnp to acnp career moves, allowing for expanded clinical expertise relevant to immunology-related patient care.

Accelerated study options also exist for those seeking quicker certification. Accelerated fnp programs enable students to fast-track their education while keeping clinical immunology insights in focus.

Finally, understanding the financial outlook is crucial. Many advanced degrees, including a doctorate in nursing salary statistics, reveal strong earning potential, making further education in immunology-adjacent careers a wise investment.

Best Scientists Citing Evan M. Hersh

Recently Published Articles